---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-104812"
form_type: "8-K"
ticker: "NWBO"
cik: "0001072379"
company_name: "NORTHWEST BIOTHERAPEUTICS INC"
filed_at: "2025-10-31T23:59:59+00:00"
generated_at: "2026-05-17T01:03:17.767762+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# NW Biotherapeutics enters $5.5M loan agreement with Streeterville Capital

## Summary
- Loan amount $5,505,000; maturity 22 months; interest 8% p.a.; 10% original issue discount.
- No payments for first 8 months; 14 equal monthly installments start June 2026 at 110% pro rata principal plus interest.
- Prepayment allowed with 10% charge; funds used for ongoing business operations.
- Loan includes customary default provisions and potential acceleration.

## SEC filing metadata
- accession: 0001104659-25-104812
- form_type: 8-K
- ticker: NWBO
- cik: 0001072379
- company_name: NORTHWEST BIOTHERAPEUTICS INC
- filed_at: 2025-10-31T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 2.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1072379/000110465925104812/0001104659-25-104812-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1072379/000110465925104812/tm2529815d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-104812
- JSON: https://secwatch.observer/filing/0001104659-25-104812.json
- Plain text: https://secwatch.observer/filing/0001104659-25-104812.txt

## Key facts
- Debt Financings
  NORTHWEST BIOTHERAPEUTICS INC incurred loan of $5,505,000 with Streeterville Capital, LLC at 8% per annum maturing 22 months.
  - Instrument: loan
  - Principal: $5,505,000
  - Counterparty: Streeterville Capital, LLC
  - Rate: 8% per annum
  - Maturity: 22 months
  - Event: incurrence
  source text: On October 27, 2025, Northwest Biotherapeutics, Inc. (the “Company”) entered into a Commercial Loan Agreement and Note (collectively, the “Loan Agreement”) with Streeterville Capital, LLC (the “Holder”) in the amount of $5,505,000.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1072379/000110465925104812/0001104659-25-104812-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.